Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House 
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants 
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
Trump Administration Appeals Judge’s Order Limiting ICE Tactics in Minneapolis 
Former South Korean President Yoon Suk Yeol Faces Historic Court Ruling Over Failed Martial Law Attempt 
DOJ Sues Virginia Over Failure to Provide Full Voter Registration Records 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
On Monday, a U.S. appeals court ruled in favor of 3M, E.I. du Pont de Nemours and Co, and other manufacturers of "forever chemicals." The court rejected a lower court's ruling, allowing approximately 11.8 million Ohio residents to sue the companies.
Reuters noted that the ruling relieves considerable legal pressure placed on the chemical manufacturers to settle the plaintiffs' claims.
Court Ruling Questions Class Action Suit's Validity
According to Yahoo, Lead plaintiff Kevin Hardwick's complaint against the manufacturers faced scrutiny from the court. The appeals court found his complaint to be overly broad and lacking evidence that the per- and polyfluoroalkyl substances (PFAS) detected in his body could be directly attributed to the defendants.
The court emphasized that the complaint targeted the collective actions of the companies rather than individual responsibility. Notably, the case involved just 10 out of thousands of companies involved in PFAS manufacturing.
The lower court's approval of the class action suit has been vacated, and the court instructed the dismissal of Hardwick's lawsuit. The lawsuit aimed to hold the companies accountable for the health impacts of PFAS exposure and sought to establish a fund to monitor Ohio residents.
Additionally, Hardwick's request for the companies to fund studies on the health effects of PFAS was denied. These forever chemicals, commonly found in consumer products, have been linked to cancer and other diseases.
Robert Bilott, attorney for Hardwick, expressed disappointment with the court's decision. He stated that it contradicts what is known about the history of PFAS manufacturing in the United States. Bilott's legal team is currently evaluating whether to appeal the ruling further.
The Persistence and Prevalence of Forever Chemicals
PFAS substances earned the nickname "forever chemicals" due to their resistance to breaking down in nature or in the human body. The growing number of lawsuits filed against 3M, DuPont, and other manufacturers in recent years reflect concerns over alleged PFAS contamination.
In June, 3M agreed to pay $10.3 billion to settle hundreds of claims regarding public drinking water pollution caused by PFAS. Furthermore, Chemours Co, DuPont de Nemours Inc, and Corteva reached a similar settlement worth $1.19 billion with U.S. water providers.
Photo: 3M News Center
